11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 5,400,000 | $5,031,180 | 0.26% | ||
| 2. | 5,023,000 | $4,699,598 | +1091% | 0.04% | |
| 3. | Hurley Capital Charles Goldblum | 1,435 | $91,582 | +140% | 0.07% |
| 4. | 20,000 | $1,276 | 0.69% | ||
| 5. | Altium Capital Jacob Gottlieb | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $134.66 | 5,648 | 284,034 | 2024-08-16 | Filing | ||
| $134.06 | 18,284 | 278,386 | 2024-08-16 | Filing | ||
| $133.07 | 13,106 | 260,102 | 2024-08-16 | Filing | ||
| $78.81 | 40,000 | Director | 140,000 | 2023-11-03 | Filing | |
| $78.81 | 10,000 | Director | 10,000 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.64 | 2,491 | 27,812 | 2025-03-12 | Filing | ||
| $124.84 | 10,500 | 22,840 | 2024-12-12 | Filing | ||
| $125.55 | 1,636 | 5,880 | 2024-12-05 | Filing | ||
| $137.36 | 5,985 | 33,946 | 2024-08-30 | Filing | ||
| $164.52 | 2,549 | 17,129 | 2024-06-25 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,906,868 | $632,256,316 | 0.01% | |
| 2. | 9,032,613 | $576,461,361 | 0.01% | |
| 3. | 1,663,573 | $106,169,229 | 0.04% | |
| 4. | 937,023 | $60,727,757 | 0.07% | |
| 5. | 59,159,000 | $55,146,245 | 0.24% |
News See All
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded.
11 Oversold NASDAQ Stocks to Buy Right Now
On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look at in the current market...
Billionaire George Soros' 10 Small-Cap Stocks with Huge Upside Potential
When a legendary investor like George Soros makes a move, Wall Street pays attention.
11 Most Promising Long-Term Stocks According to Analysts
On March 31, Banrion's Shana Sissel recently appeared on CNBC's 'Power Lunch' to discuss that buying at lower valuations is favorable for long-term investors.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, today’s program is being recorded.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...
15 Best Fast Growth Stocks To Buy Right Now
In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market expectations of 2.7% and a deceleration from the 3.1% growth observed in the...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.